Characterization of phenolics, in vitro reducing capacity and anti-glycation activity of red grape skins recovered from winemaking by-products
•Phenolic characterization of red grape skins was performed by UPLC-DAD-MS.•Glycation was studied by bovine serum albumin-fructose/methylglyoxal model systems.•Red grape skins had high anti-glycation efficacy compared to nutraceutical products.•Red grape skins can be cost-effective sources to preven...
Gespeichert in:
Veröffentlicht in: | Bioresource technology 2013-07, Vol.140, p.263-268 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Phenolic characterization of red grape skins was performed by UPLC-DAD-MS.•Glycation was studied by bovine serum albumin-fructose/methylglyoxal model systems.•Red grape skins had high anti-glycation efficacy compared to nutraceutical products.•Red grape skins can be cost-effective sources to prevent hyperglycemia’s complications.
Red grape skins recovered from ten winemaking processes were analyzed for total phenolic content (Folin Ciocalteu assay), proanthocyanidins (n-butanol/HCl assay), individual phenolics (UPLC-DAD-MS), in vitro ferric ion reducing capacity and anti-glycation activity by bovine serum albumin/fructose and bovine serum albumin/methylglyoxal model systems. The aim was to assess if these by-products have potential as dietary anti-glycation agents, to prevent the glyco-oxidative stress associated with type-2 diabetes.
Variability was observed in total phenolics (12.1–53.6g gallic acid Eq/kg), proanthocyanidins (7.2–51.1g/kg), anthocyanins (2.5–13.8g malvidin 3-O glucoside Eq/kg), flavonols (0.3–2.6g quercetin 3-O glucoside Eq/kg) and reducing capacity (103–511mmol Fe(II) Eq/kg). For all samples, the anti-glycation effectiveness was higher than that of commercial nutraceutical preparations. Hence, in spite of differences in cultivar, location of the vineyard and winemaking procedures, these by-products could be used as a source of cost-effective anti-glycation agent either as a food ingredient or as a nutraceutical preparation. |
---|---|
ISSN: | 0960-8524 1873-2976 |
DOI: | 10.1016/j.biortech.2013.04.092 |